-
Full-Life Technologies Announces US$77 Million Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Manufacturing Capabilities
[ 메디채널 김갑성 기자 ] Series C led by Junson Capital along with new investor syndicate and existing shareholders Funding will further advance Full-Life's global radiopharmaceutical pipeline and manufacturing capabilities in Belgium Additional debt financing provides an alternative financing solution for Full-Life's future development CHENGDU, China and GEMBLOUX, Belgium, Sept. 30, 2025 -- Full-Life Technologies ("Full-Life", the "Company"), a fully-integrated global radiotherapeutics company, today announced the completion of US$77 million financing, comprised of
- 김갑성 기자
- 2025-09-30 08:00
-
Locus Cell's Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU with Cambium Bio
TAIPEI, Sept. 30, 2025 -- Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium Bio (ASX: CMB). Under the agreement, Cambium will entrust Locus Cell with the contract development and manufacturing (CDMO) of Elate Ocular® -related. Elate Ocular®, a Phase III dry eye disease therapy currently under clinical trials in Taiwan, the U.S., and Australia. The technology originates from Cambium's parent company, Zheng Yang Biomedical Technology Co., Ltd. Jiunn-Rong Chiou,
- 김갑성 기자
- 2025-09-30 07:00
-
United Imaging Announces the uDR® Aurora CX
[ 메디채널 김갑성 기자 ] "Designed for Freedom," the newly FDA-cleared system will be showcased at RSNA. HOUSTON, Sept. 30, 2025 -- United Imaging has announced its new digital radiography system, uDR Aurora CX, which is intended to introduce computer vision, automation, and AI diagnostics into one of the most widely used imaging modalities in healthcare. At the core of uDR Aurora CX is the uVERA platform which provides vision enabled robotics and AI into United Imaging's digital radiography portfolio. The uDR Aurora comes with two uAI® Vision Cameras integrated into th
- 김갑성 기자
- 2025-09-30 00:00
-
Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers
NEW YORK and SYDNEY, Sept. 30, 2025 -- Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, today announced a multi-year agreement with Smarter Radiation Oncology® (SRO), a company incubated by Northwell Health. Together, the organizations will advance the delivery of high-quality, standardized radiation therapy by combining Lumonus AI with SRO's evidence-based treatment protocols. Developed at Northwell Health, the largest health system in New York State, SRO's model for radiation therapy has
- 김갑성 기자
- 2025-09-30 00:00
-
Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month
Innovative Campaign Focuses on Early Detection and Empowering Education Throughout October CASTRES, France, Sept. 29, 2025 -- Pierre Fabre Laboratories is proud to announce the launch of a worldwide initiative in collaboration with the Know Your Lemons Foundation timed to coincide with Breast Cancer Awareness Month this October. This strategic partnership embodies our unwavering commitment to breast cancer prevention and supports the global mission of early detection through accessible and innovative education. Founded in 2014 by Corrine Ellsworth Beaumont, the Know Your
- 김갑성 기자
- 2025-09-29 23:36
-
트라이넷엑스, 2025년 글로벌 헬스케어 소프트웨어 부문 상위 25대 기업에 선정
'헬스케어 테크놀로지 리포트'의 이번 선정으로 트라이넷엑스는 실제 데이터, AI, 임상 연구 혁신 분야에서 이룬 혁신 입증 케임브리지, 매사추세츠주, 2025년 9월 29일 -- 세계에서 가장 광범위한 연합형 실사용 데이터(real-world data)와 증거 네트워크를 구축한 기업 트라이넷엑스(TriNetX)가 '헬스케어 테크놀로지 리포트(The Healthcare Technology Report)'가 선정한 '2025년 헬스케어 소프트웨어 부문 상위 25대 기업(Top 25 Healthcare Software Companies of 2025)'에 이름을 올렸다. 회사의 빠른 성장, 혁신적인 소프트웨어 솔루션, 생명과학과 헬스케어 분야에 대한 획기적인 기여가 이 권위 있는 상 수상으로 이어졌다. 스티브 쿤드로트(Steve Kundrot) 트라이넷엑스 최고운영책임자(COO)는 "이번 수상으로 트라이넷엑스는 데이터, 지능화, 기술을 통해 의료 생태계 전반의 혁신을 주도할 목적으로 적극적으로 추진해온 비전을 인정받았다"며 "우리는 개인정보 보호 규정을 준수하는 전 세계 실사용 데
- 김갑성 기자
- 2025-09-29 22:58
-
InnoMax MedTech Chairman Jackson Shih: Bridging Technical Gaps with End-to-End Services for Medical Device Manufacturers
SHANGHAI, Sept. 29, 2025 -- From September 24 to 26, InnoMax Medical Technology Co., Ltd. (InnoMax MedTech) featured its portfolio of proprietary products at 2025 Medtec China, spanning medical imaging and respiratory care. Among them was the company's proprietary Portable Mesh Nebulizer, alongside a portable oxygen concentrator, AI-enabled sleep-assist device, injection pens, and blood glucose meters, drawing strong interest from healthcare and medtech professionals. "Our product portfolio spans several key healthcare segments—from in-vitro diagnostics and medical imaging to res
- 김갑성 기자
- 2025-09-29 22:19
-
TriNetX Named Among the Top 25 Healthcare Software Companies of 2025
Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and clinical research transformation. CAMBRIDGE, Mass., Sept. 29, 2025 -- TriNetX, the company behind the world's broadest federated network of real-world data (RWD) and evidence, has been named one of the Top 25 Healthcare Software Companies of 2025 by The Healthcare Technology Report. This prestigious recognition celebrates TriNetX's rapid growth, pioneering software solutions, and transformative contributions to life sciences and healthcare. &
- 김갑성 기자
- 2025-09-29 20:49
-
Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences
HHP and Hanmi will grant Gilead exclusive license to encequidar, and provide access to drug supply HONG KONG, Sept. 29, 2025 -- Health Hope Pharma Limited ("HHP") today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology. HHP is currently exploring the potential of using encequidar to develop oral drug formulations across multiple fields. The most advanced program o
- 김갑성 기자
- 2025-09-29 20:48
-
Smartee Chief Scientist Prof. Gang Shen Recognized Among World's Top 2% Scientists for Orthodontic Contributions
SHANGHAI, Sept. 29, 2025 -- Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ByBo Dental, has once again been named to the World's Top 2% Scientists list, compiled by Stanford University in partnership with Elsevier. This marks the third consecutive year Prof. Shen has earned this prestigious recognition. Notably, he was honored in both the Career-Long Impact and Single-Year Impact categories, highlighting his long-term global impact and pioneering contributions to orthodontics. Now in its eighth edition,
- 김갑성 기자
- 2025-09-29 17:56
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-11-04_TUE
- The New SkyReels Officially Launches 23:50
- China opens door wider to share more opportunities with world 23:43
- ARDY FERGUSONが名誉あるS.PELLEGRINO YOUNG CHEF ACADEMY AWARD 2025を受賞 23:24
- Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development 22:30
- IMG Announces Winner of First Student Journey Scholarship 22:00
- Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel 22:00
- NYSE Content Advisory: Pre-Market Update + BETA Technologies Raises Over $1 Billion in IPO 21:59
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 11월 05일 01시 20분